Legend Biotech position history
The shares of Legend Biotech that Avidity Partners Management LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 894,000 shares, $45M, 1.0% of portfolio
- 2021 Q4: 711,900 shares, $33M, 0.70% of portfolio, Reduce −20.4%
- 2022 Q1: 1,095,000 shares, $40M, 0.83% of portfolio, Add +53.8%
- 2022 Q2: 1,000,000 shares, $55M, 1.3% of portfolio, Reduce −8.7%
- 2022 Q3: not held, Exit
- 2022 Q4: 970,000 shares, $48M, 1.0% of portfolio, New
- 2023 Q1: 1,120,500 shares, $54M, 1.8% of portfolio, Add +15.5%
- 2023 Q2: 798,900 shares, $55M, 1.9% of portfolio, Reduce −28.7%
- 2023 Q3: 967,000 shares, $65M, 2.6% of portfolio, Add +21.0%
- 2023 Q4: 685,000 shares, $41M, 1.5% of portfolio, Reduce −29.2%
- 2024 Q1: 668,300 shares, $37M, 1.2% of portfolio, Reduce −2.4%
- 2024 Q2: 398,000 shares, $18M, 0.75% of portfolio, Reduce −40.4%
- 2024 Q3: not held, Exit
- 2024 Q4: not held
- 2025 Q1: not held
- 2025 Q2: not held
- 2025 Q3: not held
- 2025 Q4: not held
- 2026 Q1: 15,000 shares, $353K, 0.08% of portfolio, New
- 2026 Q2: 15,000 shares, $433K, 0.07% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|